Gallic Acid Prevents Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis Through Regulation of JNK2 Signaling and Smad3 Binding Activity

Scientific Reports - United Kingdom
doi 10.1038/srep34790
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Simvastatin Prevents Isoproterenol-Induced Cardiac Hypertrophy Through Modulation of the JAK/STAT Pathway

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

11β-Hsd1 Inhibition Ameliorates Diabetes-Induced Cardiomyocyte Hypertrophy and Cardiac Fibrosis Through Modulation of EGFR Activity

Oncotarget
Oncology
2017English

Cardiac .BETA.-Adrenergic Signaling Pathway Alteration in Isoproterenol-Induced Cardiac Hypertrophy in Male Sprague-Dawley Rats.

Japanese Heart Journal
1997English

Isoproterenol-Induced Cardiac Hypertrophy: Role of Circulatory Versus Cardiac Renin-Angiotensin System

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Role of Cardiac Angiotensin II in Isoproterenol-Induced Left Ventricular Hypertrophy.

Hypertension
Internal Medicine
1992English

Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition

Hypertension
Internal Medicine
2003English

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

PLoS ONE
Multidisciplinary
2013English

Gentisic Acid Prevents the Transition From Pressure Overload-Induced Cardiac Hypertrophy to Heart Failure

Scientific Reports
Multidisciplinary
2019English

Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy